Latest Biotech Financial Results News

Page 1 of 1

PolyNovo’s Revenue Surges 25% Amid R&D Setbacks and FDA Prep

PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.

Ada Torres

20 Feb 2026

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026